nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—SLC29A1—Didanosine—acquired immunodeficiency syndrome	0.3	0.727	CbGbCtD
Fludarabine—Nelarabine—Abacavir—acquired immunodeficiency syndrome	0.175	0.417	CrCrCtD
Fludarabine—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.157	0.375	CrCrCtD
Fludarabine—DCK—Lamivudine—acquired immunodeficiency syndrome	0.113	0.274	CbGbCtD
Fludarabine—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.0868	0.208	CrCrCtD
Fludarabine—Cladribine—POLE3—acquired immunodeficiency syndrome	0.0025	1	CrCbGaD
Fludarabine—POLA1—retina—acquired immunodeficiency syndrome	0.00164	0.0453	CbGeAlD
Fludarabine—SLC28A3—digestive system—acquired immunodeficiency syndrome	0.00164	0.0453	CbGeAlD
Fludarabine—SLC28A3—bone marrow—acquired immunodeficiency syndrome	0.00151	0.0417	CbGeAlD
Fludarabine—SLC28A3—lung—acquired immunodeficiency syndrome	0.00137	0.0378	CbGeAlD
Fludarabine—RRM1—retina—acquired immunodeficiency syndrome	0.0013	0.036	CbGeAlD
Fludarabine—RRM1—skin of body—acquired immunodeficiency syndrome	0.00114	0.0316	CbGeAlD
Fludarabine—POLA1—blood—acquired immunodeficiency syndrome	0.00109	0.0303	CbGeAlD
Fludarabine—POLA1—bone marrow—acquired immunodeficiency syndrome	0.00106	0.0293	CbGeAlD
Fludarabine—POLA1—vagina—acquired immunodeficiency syndrome	0.00101	0.0281	CbGeAlD
Fludarabine—DCK—retina—acquired immunodeficiency syndrome	0.00101	0.0279	CbGeAlD
Fludarabine—POLA1—lung—acquired immunodeficiency syndrome	0.00096	0.0266	CbGeAlD
Fludarabine—RRM1—lymphoid tissue—acquired immunodeficiency syndrome	0.000924	0.0256	CbGeAlD
Fludarabine—RRM1—digestive system—acquired immunodeficiency syndrome	0.000912	0.0253	CbGeAlD
Fludarabine—RRM1—blood—acquired immunodeficiency syndrome	0.000869	0.0241	CbGeAlD
Fludarabine—RRM1—bone marrow—acquired immunodeficiency syndrome	0.000841	0.0233	CbGeAlD
Fludarabine—RRM1—spinal cord—acquired immunodeficiency syndrome	0.000837	0.0232	CbGeAlD
Fludarabine—RRM1—vagina—acquired immunodeficiency syndrome	0.000806	0.0223	CbGeAlD
Fludarabine—RRM1—lung—acquired immunodeficiency syndrome	0.000762	0.0211	CbGeAlD
Fludarabine—SLC29A1—lymphoid tissue—acquired immunodeficiency syndrome	0.000751	0.0208	CbGeAlD
Fludarabine—SLC29A1—digestive system—acquired immunodeficiency syndrome	0.000742	0.0205	CbGeAlD
Fludarabine—DCK—lymphoid tissue—acquired immunodeficiency syndrome	0.000717	0.0199	CbGeAlD
Fludarabine—DCK—digestive system—acquired immunodeficiency syndrome	0.000709	0.0196	CbGeAlD
Fludarabine—SLC29A1—blood—acquired immunodeficiency syndrome	0.000707	0.0196	CbGeAlD
Fludarabine—RRM1—nervous system—acquired immunodeficiency syndrome	0.000706	0.0195	CbGeAlD
Fludarabine—SLC29A1—bone marrow—acquired immunodeficiency syndrome	0.000684	0.0189	CbGeAlD
Fludarabine—POLA1—brain—acquired immunodeficiency syndrome	0.000679	0.0188	CbGeAlD
Fludarabine—RRM1—central nervous system—acquired immunodeficiency syndrome	0.000679	0.0188	CbGeAlD
Fludarabine—DCK—blood—acquired immunodeficiency syndrome	0.000675	0.0187	CbGeAlD
Fludarabine—POLA1—lymph node—acquired immunodeficiency syndrome	0.000657	0.0182	CbGeAlD
Fludarabine—SLC29A1—vagina—acquired immunodeficiency syndrome	0.000655	0.0181	CbGeAlD
Fludarabine—DCK—bone marrow—acquired immunodeficiency syndrome	0.000653	0.0181	CbGeAlD
Fludarabine—DCK—spinal cord—acquired immunodeficiency syndrome	0.00065	0.018	CbGeAlD
Fludarabine—DCK—vagina—acquired immunodeficiency syndrome	0.000626	0.0173	CbGeAlD
Fludarabine—SLC29A1—lung—acquired immunodeficiency syndrome	0.00062	0.0171	CbGeAlD
Fludarabine—DCK—lung—acquired immunodeficiency syndrome	0.000592	0.0164	CbGeAlD
Fludarabine—SLC29A1—nervous system—acquired immunodeficiency syndrome	0.000574	0.0159	CbGeAlD
Fludarabine—SLC29A1—central nervous system—acquired immunodeficiency syndrome	0.000552	0.0153	CbGeAlD
Fludarabine—DCK—nervous system—acquired immunodeficiency syndrome	0.000548	0.0152	CbGeAlD
Fludarabine—RRM1—brain—acquired immunodeficiency syndrome	0.000539	0.0149	CbGeAlD
Fludarabine—DCK—central nervous system—acquired immunodeficiency syndrome	0.000528	0.0146	CbGeAlD
Fludarabine—RRM1—lymph node—acquired immunodeficiency syndrome	0.000521	0.0144	CbGeAlD
Fludarabine—SLC29A1—brain—acquired immunodeficiency syndrome	0.000439	0.0121	CbGeAlD
Fludarabine—SLC29A1—lymph node—acquired immunodeficiency syndrome	0.000424	0.0117	CbGeAlD
Fludarabine—DCK—brain—acquired immunodeficiency syndrome	0.000419	0.0116	CbGeAlD
Fludarabine—DCK—lymph node—acquired immunodeficiency syndrome	0.000405	0.0112	CbGeAlD
Fludarabine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000877	CcSEcCtD
Fludarabine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000877	CcSEcCtD
Fludarabine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000114	0.000876	CcSEcCtD
Fludarabine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000114	0.000874	CcSEcCtD
Fludarabine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000113	0.000869	CcSEcCtD
Fludarabine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000866	CcSEcCtD
Fludarabine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000864	CcSEcCtD
Fludarabine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000864	CcSEcCtD
Fludarabine—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000862	CcSEcCtD
Fludarabine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000859	CcSEcCtD
Fludarabine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000858	CcSEcCtD
Fludarabine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000111	0.000856	CcSEcCtD
Fludarabine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000855	CcSEcCtD
Fludarabine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000855	CcSEcCtD
Fludarabine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000854	CcSEcCtD
Fludarabine—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000853	CcSEcCtD
Fludarabine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000848	CcSEcCtD
Fludarabine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000845	CcSEcCtD
Fludarabine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00011	0.000842	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000842	CcSEcCtD
Fludarabine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.000841	CcSEcCtD
Fludarabine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.00084	CcSEcCtD
Fludarabine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000839	CcSEcCtD
Fludarabine—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000838	CcSEcCtD
Fludarabine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.000834	CcSEcCtD
Fludarabine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.000834	CcSEcCtD
Fludarabine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000109	0.000834	CcSEcCtD
Fludarabine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000831	CcSEcCtD
Fludarabine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.00083	CcSEcCtD
Fludarabine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000108	0.000829	CcSEcCtD
Fludarabine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.000828	CcSEcCtD
Fludarabine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000827	CcSEcCtD
Fludarabine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000108	0.000827	CcSEcCtD
Fludarabine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000826	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000826	CcSEcCtD
Fludarabine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000107	0.000822	CcSEcCtD
Fludarabine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000107	0.000822	CcSEcCtD
Fludarabine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000822	CcSEcCtD
Fludarabine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.00082	CcSEcCtD
Fludarabine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000817	CcSEcCtD
Fludarabine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000106	0.000815	CcSEcCtD
Fludarabine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000814	CcSEcCtD
Fludarabine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000814	CcSEcCtD
Fludarabine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000106	0.000814	CcSEcCtD
Fludarabine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000106	0.000814	CcSEcCtD
Fludarabine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000811	CcSEcCtD
Fludarabine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000105	0.00081	CcSEcCtD
Fludarabine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000808	CcSEcCtD
Fludarabine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000105	0.000807	CcSEcCtD
Fludarabine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000806	CcSEcCtD
Fludarabine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000105	0.000805	CcSEcCtD
Fludarabine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000805	CcSEcCtD
Fludarabine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000105	0.000804	CcSEcCtD
Fludarabine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000803	CcSEcCtD
Fludarabine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.0008	CcSEcCtD
Fludarabine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000798	CcSEcCtD
Fludarabine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000104	0.000796	CcSEcCtD
Fludarabine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000103	0.000795	CcSEcCtD
Fludarabine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000103	0.000794	CcSEcCtD
Fludarabine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000103	0.000793	CcSEcCtD
Fludarabine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000793	CcSEcCtD
Fludarabine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000791	CcSEcCtD
Fludarabine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000791	CcSEcCtD
Fludarabine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000791	CcSEcCtD
Fludarabine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000788	CcSEcCtD
Fludarabine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000788	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000783	CcSEcCtD
Fludarabine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000102	0.000782	CcSEcCtD
Fludarabine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000782	CcSEcCtD
Fludarabine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000781	CcSEcCtD
Fludarabine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000781	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000781	CcSEcCtD
Fludarabine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.00078	CcSEcCtD
Fludarabine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000775	CcSEcCtD
Fludarabine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000775	CcSEcCtD
Fludarabine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000775	CcSEcCtD
Fludarabine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.0001	0.000771	CcSEcCtD
Fludarabine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.0001	0.00077	CcSEcCtD
Fludarabine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.0001	0.000769	CcSEcCtD
Fludarabine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000769	CcSEcCtD
Fludarabine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.99e-05	0.000768	CcSEcCtD
Fludarabine—Nausea—Didanosine—acquired immunodeficiency syndrome	9.99e-05	0.000768	CcSEcCtD
Fludarabine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	9.95e-05	0.000764	CcSEcCtD
Fludarabine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	9.94e-05	0.000764	CcSEcCtD
Fludarabine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	9.94e-05	0.000763	CcSEcCtD
Fludarabine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	9.91e-05	0.000761	CcSEcCtD
Fludarabine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	9.91e-05	0.000761	CcSEcCtD
Fludarabine—Oedema—Ritonavir—acquired immunodeficiency syndrome	9.87e-05	0.000758	CcSEcCtD
Fludarabine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	9.84e-05	0.000756	CcSEcCtD
Fludarabine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	9.82e-05	0.000754	CcSEcCtD
Fludarabine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	9.79e-05	0.000752	CcSEcCtD
Fludarabine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	9.73e-05	0.000747	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	9.72e-05	0.000747	CcSEcCtD
Fludarabine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	9.69e-05	0.000745	CcSEcCtD
Fludarabine—Cough—Lamivudine—acquired immunodeficiency syndrome	9.69e-05	0.000744	CcSEcCtD
Fludarabine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	9.68e-05	0.000743	CcSEcCtD
Fludarabine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	9.66e-05	0.000742	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	9.63e-05	0.00074	CcSEcCtD
Fludarabine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	9.62e-05	0.000739	CcSEcCtD
Fludarabine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	9.62e-05	0.000739	CcSEcCtD
Fludarabine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	9.62e-05	0.000739	CcSEcCtD
Fludarabine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	9.58e-05	0.000736	CcSEcCtD
Fludarabine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	9.58e-05	0.000736	CcSEcCtD
Fludarabine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	9.54e-05	0.000733	CcSEcCtD
Fludarabine—Constipation—Efavirenz—acquired immunodeficiency syndrome	9.54e-05	0.000733	CcSEcCtD
Fludarabine—Pain—Efavirenz—acquired immunodeficiency syndrome	9.54e-05	0.000733	CcSEcCtD
Fludarabine—Rash—Nevirapine—acquired immunodeficiency syndrome	9.54e-05	0.000733	CcSEcCtD
Fludarabine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	9.53e-05	0.000732	CcSEcCtD
Fludarabine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	9.51e-05	0.000731	CcSEcCtD
Fludarabine—Oedema—Saquinavir—acquired immunodeficiency syndrome	9.5e-05	0.00073	CcSEcCtD
Fludarabine—Headache—Nevirapine—acquired immunodeficiency syndrome	9.47e-05	0.000728	CcSEcCtD
Fludarabine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	9.45e-05	0.000726	CcSEcCtD
Fludarabine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	9.45e-05	0.000726	CcSEcCtD
Fludarabine—Infection—Saquinavir—acquired immunodeficiency syndrome	9.44e-05	0.000725	CcSEcCtD
Fludarabine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	9.41e-05	0.000723	CcSEcCtD
Fludarabine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	9.39e-05	0.000722	CcSEcCtD
Fludarabine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	9.34e-05	0.000717	CcSEcCtD
Fludarabine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	9.33e-05	0.000717	CcSEcCtD
Fludarabine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	9.31e-05	0.000716	CcSEcCtD
Fludarabine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	9.31e-05	0.000716	CcSEcCtD
Fludarabine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	9.3e-05	0.000714	CcSEcCtD
Fludarabine—Vomiting—Stavudine—acquired immunodeficiency syndrome	9.28e-05	0.000713	CcSEcCtD
Fludarabine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	9.28e-05	0.000713	CcSEcCtD
Fludarabine—Rash—Nelfinavir—acquired immunodeficiency syndrome	9.24e-05	0.00071	CcSEcCtD
Fludarabine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	9.23e-05	0.000709	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	9.21e-05	0.000708	CcSEcCtD
Fludarabine—Rash—Stavudine—acquired immunodeficiency syndrome	9.21e-05	0.000707	CcSEcCtD
Fludarabine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	9.2e-05	0.000707	CcSEcCtD
Fludarabine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	9.2e-05	0.000707	CcSEcCtD
Fludarabine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	9.19e-05	0.000706	CcSEcCtD
Fludarabine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	9.18e-05	0.000705	CcSEcCtD
Fludarabine—Headache—Nelfinavir—acquired immunodeficiency syndrome	9.18e-05	0.000705	CcSEcCtD
Fludarabine—Headache—Stavudine—acquired immunodeficiency syndrome	9.15e-05	0.000703	CcSEcCtD
Fludarabine—Vomiting—Abacavir—acquired immunodeficiency syndrome	9.15e-05	0.000703	CcSEcCtD
Fludarabine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	9.14e-05	0.000702	CcSEcCtD
Fludarabine—Pain—Delavirdine—acquired immunodeficiency syndrome	9.12e-05	0.000701	CcSEcCtD
Fludarabine—Constipation—Delavirdine—acquired immunodeficiency syndrome	9.12e-05	0.000701	CcSEcCtD
Fludarabine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	9.11e-05	0.0007	CcSEcCtD
Fludarabine—Rash—Abacavir—acquired immunodeficiency syndrome	9.07e-05	0.000697	CcSEcCtD
Fludarabine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	9.06e-05	0.000696	CcSEcCtD
Fludarabine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	9.06e-05	0.000696	CcSEcCtD
Fludarabine—Oedema—Lamivudine—acquired immunodeficiency syndrome	9.06e-05	0.000696	CcSEcCtD
Fludarabine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	9.05e-05	0.000696	CcSEcCtD
Fludarabine—Headache—Abacavir—acquired immunodeficiency syndrome	9.01e-05	0.000692	CcSEcCtD
Fludarabine—Infection—Lamivudine—acquired immunodeficiency syndrome	9e-05	0.000692	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.99e-05	0.000691	CcSEcCtD
Fludarabine—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.98e-05	0.00069	CcSEcCtD
Fludarabine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.98e-05	0.00069	CcSEcCtD
Fludarabine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	8.89e-05	0.000683	CcSEcCtD
Fludarabine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	8.87e-05	0.000682	CcSEcCtD
Fludarabine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	8.86e-05	0.000681	CcSEcCtD
Fludarabine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.82e-05	0.000677	CcSEcCtD
Fludarabine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	8.8e-05	0.000676	CcSEcCtD
Fludarabine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.79e-05	0.000676	CcSEcCtD
Fludarabine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	8.76e-05	0.000673	CcSEcCtD
Fludarabine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.7e-05	0.000668	CcSEcCtD
Fludarabine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	8.7e-05	0.000668	CcSEcCtD
Fludarabine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	8.69e-05	0.000667	CcSEcCtD
Fludarabine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.68e-05	0.000667	CcSEcCtD
Fludarabine—Nausea—Stavudine—acquired immunodeficiency syndrome	8.67e-05	0.000666	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	8.65e-05	0.000665	CcSEcCtD
Fludarabine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	8.64e-05	0.000664	CcSEcCtD
Fludarabine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	8.58e-05	0.000659	CcSEcCtD
Fludarabine—Nausea—Abacavir—acquired immunodeficiency syndrome	8.54e-05	0.000656	CcSEcCtD
Fludarabine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	8.53e-05	0.000655	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	8.52e-05	0.000654	CcSEcCtD
Fludarabine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	8.51e-05	0.000654	CcSEcCtD
Fludarabine—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.47e-05	0.000651	CcSEcCtD
Fludarabine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	8.47e-05	0.000651	CcSEcCtD
Fludarabine—Pain—Ritonavir—acquired immunodeficiency syndrome	8.44e-05	0.000648	CcSEcCtD
Fludarabine—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.44e-05	0.000648	CcSEcCtD
Fludarabine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.44e-05	0.000648	CcSEcCtD
Fludarabine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	8.36e-05	0.000642	CcSEcCtD
Fludarabine—Pruritus—Indinavir—acquired immunodeficiency syndrome	8.35e-05	0.000642	CcSEcCtD
Fludarabine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	8.26e-05	0.000634	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	8.25e-05	0.000634	CcSEcCtD
Fludarabine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	8.22e-05	0.000631	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	8.2e-05	0.00063	CcSEcCtD
Fludarabine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	8.19e-05	0.000629	CcSEcCtD
Fludarabine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	8.14e-05	0.000625	CcSEcCtD
Fludarabine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	8.13e-05	0.000625	CcSEcCtD
Fludarabine—Constipation—Saquinavir—acquired immunodeficiency syndrome	8.12e-05	0.000624	CcSEcCtD
Fludarabine—Pain—Saquinavir—acquired immunodeficiency syndrome	8.12e-05	0.000624	CcSEcCtD
Fludarabine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	8.08e-05	0.000621	CcSEcCtD
Fludarabine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	8.08e-05	0.00062	CcSEcCtD
Fludarabine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	8.07e-05	0.00062	CcSEcCtD
Fludarabine—Rash—Zidovudine—acquired immunodeficiency syndrome	8e-05	0.000615	CcSEcCtD
Fludarabine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	8e-05	0.000615	CcSEcCtD
Fludarabine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	8e-05	0.000614	CcSEcCtD
Fludarabine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	7.98e-05	0.000613	CcSEcCtD
Fludarabine—Headache—Zidovudine—acquired immunodeficiency syndrome	7.95e-05	0.000611	CcSEcCtD
Fludarabine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.89e-05	0.000606	CcSEcCtD
Fludarabine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	7.88e-05	0.000605	CcSEcCtD
Fludarabine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	7.86e-05	0.000604	CcSEcCtD
Fludarabine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.83e-05	0.000601	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.82e-05	0.000601	CcSEcCtD
Fludarabine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.81e-05	0.0006	CcSEcCtD
Fludarabine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.8e-05	0.000599	CcSEcCtD
Fludarabine—Constipation—Lamivudine—acquired immunodeficiency syndrome	7.75e-05	0.000595	CcSEcCtD
Fludarabine—Pain—Lamivudine—acquired immunodeficiency syndrome	7.75e-05	0.000595	CcSEcCtD
Fludarabine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.66e-05	0.000588	CcSEcCtD
Fludarabine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.63e-05	0.000586	CcSEcCtD
Fludarabine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.55e-05	0.00058	CcSEcCtD
Fludarabine—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.54e-05	0.000579	CcSEcCtD
Fludarabine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.51e-05	0.000577	CcSEcCtD
Fludarabine—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.51e-05	0.000577	CcSEcCtD
Fludarabine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.47e-05	0.000574	CcSEcCtD
Fludarabine—Rash—Indinavir—acquired immunodeficiency syndrome	7.44e-05	0.000572	CcSEcCtD
Fludarabine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.44e-05	0.000571	CcSEcCtD
Fludarabine—Headache—Indinavir—acquired immunodeficiency syndrome	7.39e-05	0.000568	CcSEcCtD
Fludarabine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.3e-05	0.000561	CcSEcCtD
Fludarabine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	7.27e-05	0.000559	CcSEcCtD
Fludarabine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	7.16e-05	0.00055	CcSEcCtD
Fludarabine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	7.09e-05	0.000545	CcSEcCtD
Fludarabine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	7.08e-05	0.000544	CcSEcCtD
Fludarabine—Rash—Efavirenz—acquired immunodeficiency syndrome	7.03e-05	0.00054	CcSEcCtD
Fludarabine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	7.03e-05	0.00054	CcSEcCtD
Fludarabine—Nausea—Indinavir—acquired immunodeficiency syndrome	7.01e-05	0.000539	CcSEcCtD
Fludarabine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	7e-05	0.000538	CcSEcCtD
Fludarabine—Headache—Efavirenz—acquired immunodeficiency syndrome	6.99e-05	0.000537	CcSEcCtD
Fludarabine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.98e-05	0.000536	CcSEcCtD
Fludarabine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.81e-05	0.000524	CcSEcCtD
Fludarabine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.78e-05	0.000521	CcSEcCtD
Fludarabine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.75e-05	0.000519	CcSEcCtD
Fludarabine—Rash—Delavirdine—acquired immunodeficiency syndrome	6.73e-05	0.000517	CcSEcCtD
Fludarabine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.72e-05	0.000516	CcSEcCtD
Fludarabine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.72e-05	0.000516	CcSEcCtD
Fludarabine—Headache—Delavirdine—acquired immunodeficiency syndrome	6.68e-05	0.000514	CcSEcCtD
Fludarabine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.68e-05	0.000513	CcSEcCtD
Fludarabine—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.62e-05	0.000509	CcSEcCtD
Fludarabine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.5e-05	0.000499	CcSEcCtD
Fludarabine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.5e-05	0.000499	CcSEcCtD
Fludarabine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.41e-05	0.000492	CcSEcCtD
Fludarabine—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.34e-05	0.000487	CcSEcCtD
Fludarabine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	6.27e-05	0.000482	CcSEcCtD
Fludarabine—Rash—Ritonavir—acquired immunodeficiency syndrome	6.22e-05	0.000478	CcSEcCtD
Fludarabine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.22e-05	0.000478	CcSEcCtD
Fludarabine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.2e-05	0.000476	CcSEcCtD
Fludarabine—Headache—Ritonavir—acquired immunodeficiency syndrome	6.18e-05	0.000475	CcSEcCtD
Fludarabine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	6.04e-05	0.000464	CcSEcCtD
Fludarabine—Rash—Saquinavir—acquired immunodeficiency syndrome	5.99e-05	0.00046	CcSEcCtD
Fludarabine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.98e-05	0.00046	CcSEcCtD
Fludarabine—Headache—Saquinavir—acquired immunodeficiency syndrome	5.95e-05	0.000457	CcSEcCtD
Fludarabine—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.86e-05	0.00045	CcSEcCtD
Fludarabine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.76e-05	0.000443	CcSEcCtD
Fludarabine—Rash—Lamivudine—acquired immunodeficiency syndrome	5.71e-05	0.000439	CcSEcCtD
Fludarabine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.71e-05	0.000438	CcSEcCtD
Fludarabine—Headache—Lamivudine—acquired immunodeficiency syndrome	5.68e-05	0.000436	CcSEcCtD
Fludarabine—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.64e-05	0.000433	CcSEcCtD
Fludarabine—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.38e-05	0.000413	CcSEcCtD
